UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000012039
Receipt number R000012837
Scientific Title A phase I/II clinical trial of pelvic carbon-ion radiotherapy and concurrent cisplatin chemotherapy for locally advanced squamous cell carcinoma of the uterine cervix
Date of disclosure of the study information 2013/10/17
Last modified on 2021/04/21 15:20:01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A phase I/II clinical trial of pelvic carbon-ion radiotherapy and concurrent cisplatin chemotherapy for locally advanced squamous cell carcinoma of the uterine cervix

Acronym

Cervix-VI (Protocol 1302)

Scientific Title

A phase I/II clinical trial of pelvic carbon-ion radiotherapy and concurrent cisplatin chemotherapy for locally advanced squamous cell carcinoma of the uterine cervix

Scientific Title:Acronym

Cervix-VI (Protocol 1302)

Region

Japan


Condition

Condition

Uterine cervical cancer

Classification by specialty

Obstetrics and Gynecology Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the saftey and the toxicity of prophylactic radiotherapy of pelvic lymph nodes using carbon ion radiotherapy and concurrent cisplatin chemotherapy for locally advanced squamous cell carcinoma of the uterine cervix

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Phase I,II


Assessment

Primary outcomes

Acute toxicity
2-year progression free survival

Key secondary outcomes

The ratio of the patients who completed the course
Acute and late toxicies
Response rate of the local
Local control rate
Overall survival rate


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine Maneuver

Interventions/Control_1

5 weeks
Carbon ion radiotherapy: 72.0 GyE / 20 fractions
Chemotherapy: weekly cisplatin 30-40 mg / m2 for 5 weeks.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

70 years-old >=

Gender

Female

Key inclusion criteria

1. Squamous cell carcinoma of the uterine cervix
2. International Federation of Gynecology and Obstetrics (FIGO) Stage IIB(>= 4 cm in diameter), III, or IVA disease
3. No para-aortic lymph nodes >= 1 cm in minimum diameter on CT images
4. The tumor had to be grossly measurable.
5. Age between 20 and 70 years
6. Performance status 0 - 2
7. Patients with no histories of prior chemotherapy or pelvic radiotherapy for cervical cancer
8. Normal organ function
(WBC >= 3000/mm3,Hb >= 10g/dl, Plt>= 100,000/mm3, T-Bil.<= 1.5mg/dl, AST(GOT) and ALT(GPT) <= 100IU/dl, Cre <= 1.5mg/dl, CCR >= 50ml/min, ECG normal or require no treatment
9. Estimated life expectancy of _6 months
10. Written informed consent

Key exclusion criteria

1. Severe complicating illness
2. Active double cancer
3. Rectal invasion
4. History of pelvic radiotherapy
5. History of prior chemotherapy
6. medical, psychological or others reason that primary doctor think ineligible

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Masaru
Middle name
Last name Wakatsuki

Organization

National Institute for Quantum and Radiological Science and Technology

Division name

QST Hospital

Zip code

263-8555

Address

4-9-1 Anagawa, Inage-ku, Chiba-city, Chiba, 263-8555 JAPAN

TEL

043-206-3306

Email

wakkun100@yahoo.co.jp


Public contact

Name of contact person

1st name Masaru
Middle name
Last name Wakatsuki

Organization

National Institute for Quantum and Radiological Science and Technology

Division name

QST Hospital

Zip code

263-8555

Address

4-9-1 Anagawa, Inage-ku, Chiba-city, Chiba, 263-8555 JAPAN

TEL

043-206-3306

Homepage URL

http://www.nirs.go.jp/hospital/index.shtml

Email

wakkun100@yahoo.co.jp


Sponsor or person

Institute

National Institute for Quantum and Radiological Science and Technology

Institute

Department

Personal name



Funding Source

Organization

National Institute for Quantum and Radiological Science and Technology

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Institute for Quantum and Radiological Science and Technology

Address

4-9-1 Anagawa, Inage-ku, Chiba-city, Chiba, 263-8555 JAPAN

Tel

043-206-3193

Email

genkoba@nirs.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

放射線医学総合研究所(千葉県)


Other administrative information

Date of disclosure of the study information

2013 Year 10 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

4

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2013 Year 05 Month 20 Day

Date of IRB

2012 Year 05 Month 23 Day

Anticipated trial start date

2012 Year 06 Month 06 Day

Last follow-up date

2016 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2013 Year 10 Month 15 Day

Last modified on

2021 Year 04 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012837


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name